IMVT · Immunovant, Inc.

$39.25 +0.13 (+0.33%) At close · Sep 4

Russell 2000 member Rebalance outlook locked

Market Cap

$8.11B

206.55M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Venker	Chief Executive Officer	$636,618	$503,345	—	$19,010,639	—	$8,165	$20,158,767
Peter Salzmann	Former Chief Executive Officer	$39,614	—	$8,287,949	$6,269,395	—	$737,642	$15,334,600
Tiago Girao	Chief Financial Officer	$455,493	$224,396	$3,631,717	$3,293,508	—	$11,323	$7,616,437
Michael Geffner	Former Chief Medical Officer	$345,521	—	$2,564,119	$2,145,870	—	$198,579	$5,254,089
Eva Renee Barnett	Former Chief Financial Officer	$26,250	—	$1,350,946	$1,462,825	—	$387,431	$3,227,452
Melanie Gloria	Chief Operating Officer	$495,000	$245,025	$1,157,951	$1,150,095	—	$19,041	$3,067,112
Jay S. Stout	Chief Technology Officer	$495,000	$245,025	$1,157,951	$1,150,095	—	$17,650	$3,065,721
Christopher Van Tuyl	Chief Legal Officer and Corporate Secretary	$495,000	$245,025	$771,962	$766,726	—	$17,064	$2,295,777

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	Former Chief Executive Officer	$724,500	$470,925	$4,941,237	$4,539,890	—	$55,575	$10,732,127
Christopher Van Tuyl	Chief Legal Officer and Corporate Secretary	$140,292	$62,860	$3,038,084	$2,699,742	—	$7,361	$5,948,339
Melanie Gloria	Chief Operating Officer	$180,375	$79,465	$2,804,978	$2,500,844	—	$8,173	$5,573,835
Michael Geffner	Chief Medical Officer	$518,000	$233,100	$1,692,223	$1,554,789	—	$52,915	$4,051,027
Jay S. Stout	Chief Technology Officer	$481,000	$216,450	$1,692,223	$1,554,789	—	$34,891	$3,979,353
Eva Renee Barnett	Former Chief Financial Officer	$481,000	$216,450	$1,692,223	$1,554,789	—	$26,272	$3,970,734

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	Former Chief Executive Officer	$700,000	$609,000	$3,584,330	$3,619,675	—	$39,425	$8,552,430
Jay S. Stout	Chief Technology Officer	$416,875	$241,932	$1,547,000	$1,809,390	—	$24,683	$4,039,880
Julia G. Butchko	Chief Development Officer	$465,000	$269,700	$1,472,764	$1,487,281	—	$12,966	$3,707,711
Eva Renee Barnett	Former Chief Financial Officer	$465,000	$269,700	$1,288,661	$1,301,372	—	$14,236	$3,338,969

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	Former Chief Executive Officer	$625,000	$360,938	$2,251,807	$2,544,313	—	$37,760	$5,819,818
Eva Renee Barnett	Former Chief Financial Officer	$435,000	$414,430	$562,952	$636,078	—	$21,635	$2,070,095

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William L. Macias	M.D., Ph.D. Chief Medical Officer	$219,200	$94,630	$961,887	$1,142,334	—	$4,405,338	$6,823,389
Peter Salzmann	M.D., M.B.A. Chief Executive Officer	$600,000	$346,500	$3,999,997	$888,389	—	$33,455	$5,868,341
Eva Renee Barnett	M.B.A. Chief Financial Officer	$198,485	$328,027	$1,765,800	$2,126,272	—	$8,467	$4,427,051

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	M.D., M.B.A. Chief Executive Officer	$567,000	$311,850	$3,252,500	$11,104,950	—	$139,004	$15,375,304

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael J. Elliott	M.B.B.S., Ph.D., FRACP Former Chief Scientific Officer	$242,425	$96,000	$1,659,200	$14,229,311	—	$9,695	$16,236,631
Rita Jain	Former Chief Medical Officer	$101,137	$38,526	$2,703,005	$10,666,997	—	$3,319	$13,512,984
Julia G. Butchko	Chief Development and Technology Officer	$372,000	$148,800	$926,500	$6,384,856	—	$10,201	$7,842,357
Pamela Yanchik Connealy	M.B.A. Chief Financial Officer	$393,000	$157,200	$785,400	$4,258,363	—	$8,742	$5,602,705

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Salzmann	M.D., M.B.A. Chief Executive Officer	$361,010	$500,000	—	$7,721,344	$224,480	—	$8,806,834
Pamela Yanchik Connealy	M.B.A. Chief Financial Officer	$147,618	—	—	$2,437,762	$61,233	$129,321	$2,775,934

Executive changes

Person	Role	Change	Effective	Filed
Michael Geffner, M.D., M.B.A.	Chief Medical Officer	Terminated	2025-11-21	2025-11-21

Key facts CIK 1764013 CUSIP 45258J102 13F (30d) 158 filings 158 filers Visit website Investor relations